Technology-Assisted Prescription Opioid Safety Education

NCT04918446 | Completed

• 1 other identifier: 1705563584
• Study Type: interventional
• Target: 96
• Locations: 1 country
• Sites: 2

Brief Summary

This study will develop a technology-based brief educational intervention for hospitalized patients that will be discharged with an opioid prescription. The Investigators will conduct a small randomized clinical trial of T-POSE to determine whether it improves patients: knowledge and reduces the incidence of Non-Medical Prescription Opioid Use (NMPOU).

Conditions

Opioid Use

Keywords

Non-Medical Prescription Opioid Use

Outcome Measures

Primary Outcomes (1)

• Occurrence of Non-Medical Use of a Prescription Opioid

  Self report of Yes or No to follow up questions about prescription opioid use. Yes= occurrence of Non-Medical Use of a Prescription Opioid.

  Up to 90 days post intervention

Secondary Outcomes (3)

• Occurrence of retention of knowledge on how to safe use of prescription opioids

  Up to 90 days post intervention

• Number of patients reporting patient satisfaction

  Up to 90 days post intervention

• Reasons for non-medical use of prescription opioids

  Up to 90 days post intervention

Study Arms (2)

T-POSE

EXPERIMENTAL

Technology based brief educational intervention for hospitalized patients that will be discharged with an opioid prescription.

Other: T-POSE

Usual Care

OTHER

Standard discharge instructions provided.

Other: Usual Care

Interventions

T-POSE OTHER

Tablet based education and videos on opioid safety, use, and storage/disposal of the drug.

T-POSE

Usual Care OTHER

Printed instruction sheets on prescribed opioid.

Usual Care

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Subject is being discharged from the hospital with a prescription opioid
• English Speaking
• Willing and able to use a tablet
• Willing and able to provide informed written consent
• Subject is being discharged from the hospital with a prescription opioid
• English Speaking
• Willing and able to use a tablet

You may not qualify if:

• Visual or hearing impediment that would inhibit communication with the Study Pharmacist and use of the laptop
• Cognitive or mental state prohibiting informed consent
• Patient reported opioid use disorder

Sponsors & Collaborators

• West Virginia University: lead

Study Sites (2)

Cabell Huntington Hospital (Marshall University)

Huntington, West Virginia, 25755, United States

Location

West Virginia University Hospitals

Morgantown, West Virginia, 26505, United States

Location

Study Officials

• Erin Winstanley, PhD

  West Virginia University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Model Details: A small pilot study using a randomized clinical trial of T-POSE compared to usual care.

Study Record Dates

• First Submitted: June 3, 2021
• First Posted: June 8, 2021
• Study Start: March 29, 2018
• Primary Completion: February 13, 2019
• Study Completion: February 13, 2019
• Last Updated: August 12, 2021

Record last verified: 2021-06

Locations

US (2)